Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.908 SEK | -0.22% | +1.57% | -26.18% |
28/06 | Nanexa AB Announces Chief Financial Officer Changes | CI |
11/06 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB